Literature DB >> 18263985

Quality of anticoagulation control: do race and language matter?

Vijay Kumar Bhandari1, Frances Wang, Andrew B Bindman, Dean Schillinger.   

Abstract

No studies have evaluated the quality of anticoagulation control among populations characterized by low socioeconomic status, diverse racial and ethnic backgrounds, or limited English proficiency. We conducted a retrospective cohort study to evaluate the effects of race/ethnicity and language on anticoagulation outcomes among patients (N=864) receiving continuous anticoagulation services at a university-affiliated public hospital. White/non-Hispanic patients made up 24%, Asian/Pacific Islanders 33%, Hispanics 22%, African Americans 18%. English (63%), Spanish, (14%), and Cantonese (13%) were the most common languages. Mean time in therapeutic range (TTR) was 43%. After adjustment, TTR was lower for African Americans than for Whites (absolute difference, -8.7%, p< .001) and for Spanish-speaking than for English-speaking Hispanics (absolute difference, -7.2%, p< .05). There were no differences between Asian/Pacific Islanders and Whites, nor between Cantonese-speaking and English-speaking Asian/Pacific Islanders. Future research should examine mechanisms by which race/ethnicity and language affect quality of anticoagulation and evaluate programs to improve treatment in diverse communities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263985     DOI: 10.1353/hpu.2008.0002

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  12 in total

Review 1.  Review of race/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials.

Authors:  Larry R Jackson; Eric D Peterson; Eze Okeagu; Kevin Thomas
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

2.  The Intersections Between Social Determinants of Health, Health Literacy, and Health Disparities.

Authors:  Dean Schillinger
Journal:  Stud Health Technol Inform       Date:  2020-06-25

Review 3.  Disparities in the provision of medical care: an outcome in search of an explanation.

Authors:  Elizabeth A Klonoff
Journal:  J Behav Med       Date:  2009-01-06

4.  A comparison of educational interventions to enhance cultural competency in pharmacy students.

Authors:  Ibrahim Sales; Lauren Jonkman; Sharon Connor; Deanne Hall
Journal:  Am J Pharm Educ       Date:  2013-05-13       Impact factor: 2.047

Review 5.  Racial and Ethnic Disparities in Adverse Drug Events: A Systematic Review of the Literature.

Authors:  Avi Baehr; Juliet C Peña; Dale J Hu
Journal:  J Racial Ethn Health Disparities       Date:  2015-03-24

6.  Evaluation of language concordant, patient-centered drug label instructions.

Authors:  Stacy Cooper Bailey; Urmimala Sarkar; Alice Hm Chen; Dean Schillinger; Michael S Wolf
Journal:  J Gen Intern Med       Date:  2012-03-27       Impact factor: 5.128

7.  Warfarin Monitoring in Safety-Net Health Systems: Analysis by Race/Ethnicity and Language Preference.

Authors:  Anjana E Sharma; Elaine C Khoong; Natalie Rivadeneira; Maribel Sierra; Margaret C Fang; Neha Gupta; Rajiv Pramanik; Helen Tran; Tyler Whitezell; Valy Fontil; Shin-Yu Lee; Urmimala Sarkar
Journal:  J Gen Intern Med       Date:  2022-01-06       Impact factor: 6.473

8.  Unraveling the relationship between literacy, language proficiency, and patient-physician communication.

Authors:  Rebecca L Sudore; C Seth Landefeld; Eliseo J Pérez-Stable; Kirsten Bibbins-Domingo; Brie A Williams; Dean Schillinger
Journal:  Patient Educ Couns       Date:  2009-05-12

9.  Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.

Authors:  Leiliane Rodrigues Marcatto; Luciana Sacilotto; Carolina Tosin Bueno; Mirella Facin; Celia Maria Cassaro Strunz; Francisco Carlos Costa Darrieux; Maurício Ibrahim Scanavacca; Jose Eduardo Krieger; Alexandre Costa Pereira; Paulo Caleb Junior Lima Santos
Journal:  BMC Cardiovasc Disord       Date:  2016-11-17       Impact factor: 2.298

10.  Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation.

Authors:  Leiliane Rodrigues Marcatto; Luciana Sacilotto; Francisco Carlos da Costa Darrieux; Denise Tessariol Hachul; Maurício Ibrahim Scanavacca; Jose Eduardo Krieger; Alexandre Costa Pereira; Paulo Caleb Junior Lima Santos
Journal:  Oncotarget       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.